A growing number of bispecific fragment formats have been reported. Many bispecific fragments lack Fc domain, they have short half-life and may need more frequent dosing than conventional IgGs. Based on which, many BsAb fragments can be engineered to extend their half-life by adding CH3 domain or Fc region. This class of bispecific molecules includes Diabody-Fc (Cat. BSDBF), Tandem scFv-Fc (Cat. BSFVF), scDiabody-Fc (Cat. SCDBF), Diabody-CH3 (Cat. BSDBC), scDiabody-CH3 (Cat. SCDBC), etc.
CAT# | Product Name | Species Reactivity | BsAb Type | Target 1 | Target 2 | INQUIRY |
---|---|---|---|---|---|---|
BSDBF-100 | Recombinant Anti-CD3 x Anti-PSA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | PSA | Inquiry |
BSDBF-099 | Recombinant Anti-CD3 x Anti-PLAP Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | PLAP | Inquiry |
BSDBF-098 | Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | PD1 | Inquiry |
BSDBF-097 | Recombinant Anti-CD3 x Anti-p97 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | p97 | Inquiry |
BSDBF-096 | Recombinant Anti-CD3 x Anti-P cadherin Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | P cadherin | Inquiry |
BSDBF-095 | Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | MUC1 | Inquiry |
BSDBF-094 | Recombinant Anti-CD3 x Anti-CSPG4 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CSPG4 | Inquiry |
BSDBF-093 | Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | IL2R | Inquiry |
BSDBF-092 | Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | IGF1R | Inquiry |
BSDBF-091 | Recombinant Anti-CD3 x Anti-HN Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | HN | Inquiry |
BSDBF-090 | Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | HER2 | Inquiry |
BSDBF-089 | Recombinant Anti-CD3 x Anti-HBVgp3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | HBVgp3 | Inquiry |
BSDBF-088 | Recombinant Anti-CD3 x Anti-GPNMB Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | GPNMB | Inquiry |
BSDBF-087 | Recombinant Anti-CD3 x Anti-GPC3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | GPC3 | Inquiry |
BSDBF-086 | Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | gpA33 | Inquiry |
BSDBF-085 | Recombinant Anti-CD3 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | HIV-1 gp41 | Inquiry |
BSDBF-084 | Recombinant Anti-CD3 x Anti-HIV-1 gp120 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | HIV-1 gp120 | Inquiry |
BSDBF-083 | Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | GD2 | Inquiry |
BSDBF-082 | Recombinant Anti-CD3 x Anti-FOLR1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | FOLR1 | Inquiry |
BSDBF-081 | Recombinant Anti-CD3 x Anti-FcRH5 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | FcRH5 | Inquiry |
BSDBF-080 | Recombinant Anti-CD3 x Anti-FAP Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | FAP | Inquiry |
BSDBF-079 | Recombinant Anti-CD3 x Anti-EPCAM Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | EPCAM | Inquiry |
BSDBF-078 | Recombinant Anti-CD3 x Anti-CD248 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD248 | Inquiry |
BSDBF-077 | Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | EGFR | Inquiry |
BSDBF-076 | Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | DLL3 | Inquiry |
BSDBF-075 | Recombinant Anti-CD3 x Anti-CXCR5 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CXCR5 | Inquiry |
BSDBF-074 | Recombinant Anti-CD3 x Anti-MET Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | MET | Inquiry |
BSDBF-073 | Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CLEC12A | Inquiry |
BSDBF-072 | Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CEA | Inquiry |
BSDBF-071 | Recombinant Anti-CD3 x Anti-CD8 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD8 | Inquiry |
BSDBF-070 | Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD79B | Inquiry |
BSDBF-069 | Recombinant Anti-CD3 x Anti-CD74 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD74 | Inquiry |
BSDBF-068 | Recombinant Anti-CD3 x Anti-CD44 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD44 | Inquiry |
BSDBF-067 | Recombinant Anti-CD3 x Anti-CD4 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD4 | Inquiry |
BSDBF-066 | Recombinant Anti-CD3 x Anti-CD33 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD33 | Inquiry |
BSDBF-065 | Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | CD30 | Inquiry |
BSDBF-064 | Recombinant Anti-CD3 x Anti-B7H3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD3 | B7H3 | Inquiry |
BSDBF-063 | Recombinant Anti-CD28 x Anti-CSPG4 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | CSPG4 | Inquiry |
BSDBF-062 | Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | MUC1 | Inquiry |
BSDBF-061 | Recombinant Anti-CD28 x Anti-HN Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | HN | Inquiry |
BSDBF-060 | Recombinant Anti-CD28 x Anti-FOLR1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | FOLR1 | Inquiry |
BSDBF-059 | Recombinant Anti-CD28 x Anti-EPCAM Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | EPCAM | Inquiry |
BSDBF-058 | Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | EGFR | Inquiry |
BSDBF-057 | Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | CD44 | Inquiry |
BSDBF-056 | Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | CD40 | Inquiry |
BSDBF-055 | Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | CD30 | Inquiry |
BSDBF-054 | Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD28 | CD3 | Inquiry |
BSDBF-053 | Recombinant Anti-CD22 x Anti-Saporin Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD22 | Saporin | Inquiry |
BSDBF-052 | Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD20 | CD47 | Inquiry |
BSDBF-051 | Recombinant Anti-CD20 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD20 | CD3 | Inquiry |
BSDBF-050 | Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD20 | CD28 | Inquiry |
BSDBF-049 | Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD20 | CD22 | Inquiry |
BSDBF-048 | Recombinant Anti-CD2 x Anti-TCR (Vβ8) Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | CD2 | TCR (Vβ8) | Inquiry |
BSDBF-047 | Recombinant Anti-CD2 x Anti-MUC1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD2 | MUC1 | Inquiry |
BSDBF-046 | Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD2 | EGFR | Inquiry |
BSDBF-045 | Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD89 | Inquiry |
BSDBF-044 | Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD64 | Inquiry |
BSDBF-043 | Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD59 | Inquiry |
BSDBF-042 | Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD47 | Inquiry |
BSDBF-041 | Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD3 | Inquiry |
BSDBF-040 | Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD28 | Inquiry |
BSDBF-039 | Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD19 | CD22 | Inquiry |
BSDBF-038 | Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD16 | HER2 | Inquiry |
BSDBF-037 | Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD16 | GD2 | Inquiry |
BSDBF-036 | Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD16 | EGFR | Inquiry |
BSDBF-035 | Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD16 | CD32B | Inquiry |
BSDBF-034 | Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD16 | CD30 | Inquiry |
BSDBF-033 | Recombinant Anti-CD15 x Anti-DENV Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD15 | DENV | Inquiry |
BSDBF-032 | Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD15 | CD64 | Inquiry |
BSDBF-031 | Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD133 | EGFR | Inquiry |
BSDBF-030 | Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CD123 | CD3 | Inquiry |
BSDBF-029 | Recombinant Anti-CCR5 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CCR5 | CD3 | Inquiry |
BSDBF-028 | Recombinant Anti-CCR3 x Anti-CD300 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CCR3 | CD300 | Inquiry |
BSDBF-027 | Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CA72-4 | CD3 | Inquiry |
BSDBF-026 | Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CA19-9 | CD3 | Inquiry |
BSDBF-025 | Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | CA125 | HER2 | Inquiry |
BSDBF-024 | Recombinant Anti-C5 x Anti-HRP Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | C5 | HRP | Inquiry |
BSDBF-023 | Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | C. albicans | CD64 | Inquiry |
BSDBF-022 | Recombinant Anti-Biotin x Anti-HRP Bispecific Antibody (Diabody-Fc) | Constant Domain-extended Bispecific Fragments | Biotin | HRP | Inquiry | |
BSDBF-021 | Recombinant Anti-BCMA x Anti-TACI Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | BCMA | TACI | Inquiry |
BSDBF-020 | Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | BCMA | CD3 | Inquiry |
BSDBF-019 | Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | BAFF | IL17 | Inquiry |
BSDBF-018 | Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | BAFF | B7RP1 | Inquiry |
BSDBF-017 | Recombinant Anti-B7H6 x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | B7H6 | CD3 | Inquiry |
BSDBF-016 | Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | B Cell Lymphoma BCL1 Idiotype | CD3 | Inquiry |
BSDBF-015 | Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | B Cell Lymphoma A20-HL Idiotype | CD3 | Inquiry |
BSDBF-014 | Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | B Cell Lymphoma 38C13 Idiotype | LFA-1 | Inquiry |
BSDBF-013 | Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | B Cell Lymphoma 38C13 Idiotype | CD44 | Inquiry |
BSDBF-012 | Recombinant Anti-AR x Anti-DNA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | AR | DNA | Inquiry |
BSDBF-011 | Recombinant Anti-AP (Alkaline Phosphatase) x Anti-LPA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | AP (Alkaline Phosphatase) | LPA | Inquiry |
BSDBF-010 | Recombinant Anti-AP (Alkaline Phosphatase) x Anti-CEA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | AP (Alkaline Phosphatase) | CEA | Inquiry |
BSDBF-009 | Recombinant Anti-AP (Alkaline Phosphatase) x Anti-7-OHC (7-hydroxycoumarin) Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | AP (Alkaline Phosphatase) | 7-OHC (7-hydroxycoumarin) | Inquiry |
BSDBF-008 | Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Ang2 | VEGFA | Inquiry |
BSDBF-007 | Recombinant Anti-Albumin x Anti-TNF Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Albumin | TNF | Inquiry |
BSDBF-006 | Recombinant Anti-Albumin x Anti-IL-6R Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Albumin | IL-6R | Inquiry |
BSDBF-005 | Recombinant Anti-Ad Fiber Knob x Anti-ITGAV Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Ad Fiber Knob | ITGAV | Inquiry |
BSDBF-004 | Recombinant Anti-Ad Fiber Knob x Anti-EPCAM Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Ad Fiber Knob | EPCAM | Inquiry |
BSDBF-003 | Recombinant Anti-Ad Fiber Knob x Anti-CEA Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Ad Fiber Knob | CEA | Inquiry |
BSDBF-002 | Recombinant Anti-Ad Fiber Knob x Anti-CD40 Bispecific Antibody (Diabody-Fc) | Human | Constant Domain-extended Bispecific Fragments | Ad Fiber Knob | CD40 | Inquiry |
BSDBF-001 | Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Diabody-Fc) | Mouse | Constant Domain-extended Bispecific Fragments | B Cell Lymphoma BCL1 Idiotype | CD64 | Inquiry |
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS